annual current assets:
$745.13M+$235.14M(+46.11%)Summary
- As of today (July 1, 2025), PCRX annual total current assets is $745.13 million, with the most recent change of +$235.14 million (+46.11%) on December 31, 2024.
- During the last 3 years, PCRX annual current assets has fallen by -$120.92 million (-13.96%).
- PCRX annual current assets is now -13.96% below its all-time high of $866.05 million, reached on December 31, 2021.
Performance
PCRX Current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current assets:
$759.96M+$14.83M(+1.99%)Summary
- As of today (July 1, 2025), PCRX quarterly total current assets is $759.96 million, with the most recent change of +$14.83 million (+1.99%) on March 31, 2025.
- Over the past year, PCRX quarterly current assets has increased by +$216.85 million (+39.93%).
- PCRX quarterly current assets is now -12.25% below its all-time high of $866.05 million, reached on December 31, 2021.
Performance
PCRX quarterly current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
PCRX Current assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.1% | +39.9% |
| 3 y3 years | -14.0% | +13.9% |
| 5 y5 years | +82.4% | +76.1% |
PCRX Current assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.0% | +49.5% | at high | +102.1% |
| 5 y | 5-year | -14.0% | +82.4% | -12.3% | +102.1% |
| alltime | all time | -14.0% | +5837.8% | -12.3% | +5956.0% |
PCRX Current assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $759.96M(+2.0%) |
| Dec 2024 | $808.39M(-24.1%) | $745.13M(+8.0%) |
| Sep 2024 | - | $689.97M(+9.1%) |
| Jun 2024 | - | $632.21M(+16.4%) |
| Mar 2024 | - | $543.11M(+6.5%) |
| Dec 2023 | $1.06B(-10.0%) | $509.99M(+14.0%) |
| Sep 2023 | - | $447.25M(+4.2%) |
| Jun 2023 | - | $429.32M(+14.1%) |
| Mar 2023 | - | $376.11M(-24.5%) |
| Dec 2022 | $1.18B(-2.2%) | $498.33M(-6.6%) |
| Sep 2022 | - | $533.41M(+1.4%) |
| Jun 2022 | - | $526.21M(-21.1%) |
| Mar 2022 | - | $667.02M(-23.0%) |
| Dec 2021 | $1.21B(+94.1%) | $866.05M(+5.3%) |
| Sep 2021 | - | $822.35M(+3.8%) |
| Jun 2021 | - | $792.58M(+10.0%) |
| Mar 2021 | - | $720.25M(+10.5%) |
| Dec 2020 | $622.89M(+47.4%) | $651.62M(-1.0%) |
| Sep 2020 | - | $658.52M(+44.5%) |
| Jun 2020 | - | $455.82M(+5.6%) |
| Mar 2020 | - | $431.59M(+5.6%) |
| Dec 2019 | $422.51M(+99.9%) | $408.56M(+7.8%) |
| Sep 2019 | - | $378.85M(-4.0%) |
| Jun 2019 | - | $394.61M(-22.4%) |
| Mar 2019 | - | $508.67M(+6.4%) |
| Dec 2018 | $211.38M(-10.9%) | $477.97M(+1.3%) |
| Sep 2018 | - | $472.05M(+3.7%) |
| Jun 2018 | - | $455.05M(+8.7%) |
| Mar 2018 | - | $418.73M(+7.1%) |
| Dec 2017 | $237.26M | $391.11M(+6.9%) |
| Sep 2017 | - | $365.83M(-18.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $450.99M(+0.7%) |
| Mar 2017 | - | $447.96M(+84.3%) |
| Dec 2016 | $148.38M(+9.8%) | $243.09M(+3.2%) |
| Sep 2016 | - | $235.44M(-8.7%) |
| Jun 2016 | - | $257.99M(+3.8%) |
| Mar 2016 | - | $248.63M(-1.6%) |
| Dec 2015 | $135.15M(+20.9%) | $252.58M(+8.4%) |
| Sep 2015 | - | $233.10M(+1.5%) |
| Jun 2015 | - | $229.63M(+4.5%) |
| Mar 2015 | - | $219.75M(+2.6%) |
| Dec 2014 | $111.81M(+77.3%) | $214.26M(+7.5%) |
| Sep 2014 | - | $199.24M(-4.6%) |
| Jun 2014 | - | $208.91M(+112.1%) |
| Mar 2014 | - | $98.48M(-7.7%) |
| Dec 2013 | $63.07M(+23.3%) | $106.75M(-4.4%) |
| Sep 2013 | - | $111.69M(-8.1%) |
| Jun 2013 | - | $121.49M(-5.8%) |
| Mar 2013 | - | $128.99M(+111.7%) |
| Dec 2012 | $51.13M(+65.8%) | $60.92M(-28.4%) |
| Sep 2012 | - | $85.13M(-14.9%) |
| Jun 2012 | - | $100.08M(+60.7%) |
| Mar 2012 | - | $62.26M(-24.7%) |
| Dec 2011 | $30.84M(-13.1%) | $82.65M(+90.4%) |
| Sep 2011 | - | $43.40M(-19.0%) |
| Jun 2011 | - | $53.60M(-16.3%) |
| Mar 2011 | - | $64.03M(+106.2%) |
| Dec 2010 | $35.51M(+13.1%) | $31.05M(+52.3%) |
| Sep 2010 | - | $20.39M(+7.7%) |
| Jun 2010 | - | $18.93M(+50.9%) |
| Dec 2009 | $31.41M(+0.7%) | $12.55M |
| Dec 2008 | $31.18M | - |
FAQ
- What is Pacira BioSciences annual total current assets?
- What is the all time high annual current assets for Pacira BioSciences?
- What is Pacira BioSciences annual current assets year-on-year change?
- What is Pacira BioSciences quarterly total current assets?
- What is the all time high quarterly current assets for Pacira BioSciences?
- What is Pacira BioSciences quarterly current assets year-on-year change?
What is Pacira BioSciences annual total current assets?
The current annual current assets of PCRX is $745.13M
What is the all time high annual current assets for Pacira BioSciences?
Pacira BioSciences all-time high annual total current assets is $866.05M
What is Pacira BioSciences annual current assets year-on-year change?
Over the past year, PCRX annual total current assets has changed by +$235.14M (+46.11%)
What is Pacira BioSciences quarterly total current assets?
The current quarterly current assets of PCRX is $759.96M
What is the all time high quarterly current assets for Pacira BioSciences?
Pacira BioSciences all-time high quarterly total current assets is $866.05M
What is Pacira BioSciences quarterly current assets year-on-year change?
Over the past year, PCRX quarterly total current assets has changed by +$216.85M (+39.93%)